These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2981262

  • 21. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase.
    Franck T, Kohnen S, de la Rebière G, Deby-Dupont G, Deby C, Niesten A, Serteyn D.
    Vet Immunol Immunopathol; 2009 Aug 15; 130(3-4):243-50. PubMed ID: 19328559
    [Abstract] [Full Text] [Related]

  • 22. Exocytosis of a subpopulation of specific granules coincides with H2O2 production in adherent human neutrophils.
    Suchard SJ, Boxer LA.
    J Immunol; 1994 Jan 01; 152(1):290-300. PubMed ID: 8254197
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of neutrophil sulfhydryl groups by choloromethyl ketones. A mechanism for their inhibition of superoxide production.
    Tsan MF.
    Biochem Biophys Res Commun; 1983 Apr 29; 112(2):671-7. PubMed ID: 6303328
    [Abstract] [Full Text] [Related]

  • 24. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).
    Yasaka T, Boxer LA, Baehner RL.
    J Immunol; 1982 May 29; 128(5):1939-44. PubMed ID: 6278021
    [Abstract] [Full Text] [Related]

  • 25. Superoxide production by digitonin-stimulated guinea pig granulocytes. The effects of N-ethyl maleimide, divalent cations; and glycolytic and mitochondrial inhibitors on the activation of the superoxide generating system.
    Cohen HJ, Chovaniec ME.
    J Clin Invest; 1978 Apr 29; 61(4):1088-96. PubMed ID: 207722
    [Abstract] [Full Text] [Related]

  • 26. Intercellular adhesion molecule 1 and beta2 integrins in C1q-stimulated superoxide production by human neutrophils: an example of a general regulatory mechanism governing acute inflammation.
    Tyagi S, Nicholson-Weller A, Barbashov SF, Tas SW, Klickstein LB.
    Arthritis Rheum; 2000 Oct 29; 43(10):2248-59. PubMed ID: 11037884
    [Abstract] [Full Text] [Related]

  • 27. Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sites.
    Rudkowski R, Ziegler JB, Graham GG, Champion GD.
    Biochem Pharmacol; 1991 Jun 15; 41(12):1921-9. PubMed ID: 1645553
    [Abstract] [Full Text] [Related]

  • 28. Substances which aggregate neutrophils. Mechanism of action.
    O'Flaherty JT, Showell HJ, Becker EL, Ward PA.
    Am J Pathol; 1978 Jul 15; 92(1):155-66. PubMed ID: 356621
    [Abstract] [Full Text] [Related]

  • 29. Functional characterization of equine neutrophils in response to calcium ionophore A23187 and phorbol myristate acetate ex vivo.
    Moore T, Wilcke J, Chilcoat C, Eyre P, Crisman M.
    Vet Immunol Immunopathol; 1997 May 15; 56(3-4):233-46. PubMed ID: 9223228
    [Abstract] [Full Text] [Related]

  • 30. Is activation of the granulocyte by concanavalin-A a reversible process?
    Cohen HJ, Whitin JC, Chovaniec ME, Tape EH, Simons ER.
    Blood; 1984 Jan 15; 63(1):114-20. PubMed ID: 6317085
    [Abstract] [Full Text] [Related]

  • 31. Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness.
    Oseas R, Yang HH, Baehner RL, Boxer LA.
    Blood; 1981 May 15; 57(5):939-45. PubMed ID: 7214024
    [Abstract] [Full Text] [Related]

  • 32. Oxygen radical-induced erythrocyte hemolysis by neutrophils. Critical role of iron and lactoferrin.
    Vercellotti GM, van Asbeck BS, Jacob HS.
    J Clin Invest; 1985 Sep 15; 76(3):956-62. PubMed ID: 2995452
    [Abstract] [Full Text] [Related]

  • 33. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes.
    Gahr M, Speer CP, Damerau B, Sawatzki G.
    J Leukoc Biol; 1991 May 15; 49(5):427-33. PubMed ID: 1849951
    [Abstract] [Full Text] [Related]

  • 34. The inactivation of the polymorphonuclear leukocyte by non-steroidal anti-inflammatory drugs.
    Abramson S, Edelson H, Kaplan H, Given W, Weissmann G.
    Inflammation; 1984 Jun 15; 8 Suppl():S103-8. PubMed ID: 6090311
    [Abstract] [Full Text] [Related]

  • 35. Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein.
    Lainé E, Couderc R, Roch-Arveiller M, Vasson MP, Giroud JP, Raichvarg D.
    Inflammation; 1990 Feb 15; 14(1):1-9. PubMed ID: 2157658
    [Abstract] [Full Text] [Related]

  • 36. Modulation of neutrophil-reduced pyridine nucleotide content following stimulation with phorbol myristate acetate and chemotactic factors.
    Van Epps DE, Bender JG, Steinkamp JA, Chenoweth DE.
    J Leukoc Biol; 1985 Nov 15; 38(5):587-601. PubMed ID: 2995525
    [Abstract] [Full Text] [Related]

  • 37. A role for sulfhydryl groups in granulocyte aggregation.
    Kraut EH, Sagone AL.
    Blood; 1984 May 15; 63(5):1056-9. PubMed ID: 6713091
    [Abstract] [Full Text] [Related]

  • 38. Comparative superoxide-generating system of granulocytes from blood and peritoneal exudates.
    Zimmerli W, Lew PD, Cohen HJ, Waldvogel FA.
    Infect Immun; 1984 Dec 15; 46(3):625-30. PubMed ID: 6094353
    [Abstract] [Full Text] [Related]

  • 39. Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation.
    O'Flaherty JT, Kreutzer DL, Showell HJ, Ward PA.
    J Immunol; 1977 Nov 15; 119(5):1751-6. PubMed ID: 915280
    [Abstract] [Full Text] [Related]

  • 40. Opsonized zymosan-stimulated granulocytes-activation and activity of the superoxide-generating system and membrane potential changes.
    Cohen HJ, Newburger PE, Chovaniec ME, Whitin JC, Simons ER.
    Blood; 1981 Nov 15; 58(5):975-82. PubMed ID: 6271311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.